18.97
Schlusskurs vom Vortag:
$18.88
Offen:
$19.06
24-Stunden-Volumen:
244.64K
Relative Volume:
0.48
Marktkapitalisierung:
$883.31M
Einnahmen:
$502.79M
Nettoeinkommen (Verlust:
$23.71M
KGV:
37.94
EPS:
0.5
Netto-Cashflow:
$6.35M
1W Leistung:
+11.92%
1M Leistung:
+12.92%
6M Leistung:
+50.91%
1J Leistung:
+4.23%
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Vergleichen Sie CLB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CLB
Core Laboratories Inc
|
18.97 | 879.12M | 502.79M | 23.71M | 6.35M | 0.50 |
|
SLB
Slb Ltd
|
45.20 | 66.38B | 35.24B | 3.77B | 3.86B | 2.5875 |
|
BKR
Baker Hughes Company
|
49.97 | 49.54B | 27.71B | 2.93B | 2.09B | 2.9039 |
|
HAL
Halliburton Co
|
32.63 | 27.08B | 22.14B | 1.32B | 1.87B | 1.5105 |
|
FTI
Technipfmc Plc
|
50.07 | 20.00B | 9.51B | 919.70M | 1.32B | 2.12 |
|
TS
Tenaris S A Adr
|
39.96 | 20.48B | 11.79B | 2.04B | 1.91B | 3.6876 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Why Core Laboratories Inc. stock signals breakout potentialMarket Sentiment Review & Capital Protection Trade Alerts - ulpravda.ru
Trade Report: Can Core Laboratories Inc. stock sustain market leadershipJuly 2025 PostEarnings & Entry Point Strategy Guides - ulpravda.ru
Will Core Laboratories Inc. stock attract more institutional investorsPortfolio Gains Summary & Long Hold Capital Preservation Tips - ulpravda.ru
Will Core Laboratories Inc. stock deliver shareholder valueJuly 2025 Sector Moves & Free AI Powered Buy and Sell Recommendations - ulpravda.ru
Insider Buy: Is Core Laboratories Inc. stock resilient to inflationMarket Volume Summary & Consistent Profit Trade Alerts - ulpravda.ru
What catalysts could drive Core Laboratories Inc. stock higher2025 Biggest Moves & Daily Growth Stock Investment Tips - ulpravda.ru
What insider trading reveals about Core Laboratories Inc. stockEarnings Growth Summary & Daily Chart Pattern Signal Reports - ulpravda.ru
Core Laboratories Stock's Stability Makes It a Wise Hold for Now - Finviz
Core Laboratories: Providing The Technology To Replace Tier-1 Oil Inventory (NYSE:CLB) - Seeking Alpha
Is Core Laboratories Inc.'s (NYSE:CLB) Recent Stock Performance Tethered To Its Strong Fundamentals? - simplywall.st
Core Laboratories (NYSE:CLB) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL - 富途牛牛
Core Laboratories (NYSE: CLB) SVP reports vested performance share award - Stock Titan
Core Laboratories (NYSE: CLB) SVP performance share award vests at 116.5% - Stock Titan
Core Laboratories (NYSE: CLB) CFO reports performance share vesting - Stock Titan
Core Laboratories (CLB) CEO equity award vests at 116.5% of target - Stock Titan
The Truth About Core Laboratories Inc (CLB): Quiet Boomer Stock or Next Big Energy Rebound Play? - AD HOC NEWS
Earnings Miss: Is Core Laboratories Inc stock resilient to inflationJuly 2025 Movers & Verified Momentum Stock Watchlist - moha.gov.vn
Calculating The Fair Value Of Core Laboratories Inc. (NYSE:CLB) - Yahoo Finance
Is Core Laboratories Inc. stock a buy in volatile marketsChart Signals & Long-Term Growth Portfolio Plans - Улправда
Why Core Laboratories Inc. stock is a must watch tickerJuly 2025 Intraday Action & Consistent Profit Focused Trading Strategies - ulpravda.ru
Earnings Miss: Why Core Laboratories Inc. stock is a must watch tickerJuly 2025 Catalysts & Consistent Profit Trade Alerts - Улправда
Does Core Laboratories Inc. stock trade below intrinsic valueDollar Strength & Real-Time Stock Price Movement Reports - Улправда
Is Core Laboratories Inc. stock resilient to inflation2025 Market Overview & Weekly High Return Stock Forecasts - Bölüm Sonu Canavarı
Is Core Laboratories Inc. stock attractive for hedge fundsJuly 2025 Institutional & Reliable Price Breakout Alerts - DonanımHaber
Will Core Laboratories Inc. stock justify high valuation2025 Stock Rankings & Consistent Profit Focused Trading Strategies - Улправда
Can Core Laboratories Inc. stock surprise with earnings upsideTake Profit & Real-Time Buy Signal Notifications - Улправда
Core Laboratories (CLB) Falls Amid Escalating Trade Tensions - MSN
Gendell Jeffrey L Has $6.56 Million Holdings in Core Laboratories Inc. $CLB - MarketBeat
Diagnostics Testing - Abbott
Core Laboratories (CLB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Ariel Investments LLC Has $149.49 Million Stock Position in Core Laboratories Inc. $CLB - Defense World
Can Core Laboratories Inc. stock sustain double digit ROE2025 Historical Comparison & Reliable Intraday Trade Plans - Newser
Will Core Laboratories Inc. stock benefit from commodity supercycleQuarterly Trade Review & Breakout Confirmation Trade Signals - Newser
Fisher Asset Management LLC Sells 143,838 Shares of Core Laboratories Inc. $CLB - Defense World
Will Core Laboratories Inc. stock test record highs in 2025Trade Risk Assessment & Consistent Income Trade Recommendations - Newser
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now - sharewise.com
Will Core Laboratories Inc. stock keep high P E multiplesProfit Target & Low Risk High Win Rate Stock Picks - Newser
Core Laboratories (CLB) officer reports restricted stock vesting and 340-share sale - Stock Titan
Treas Teo Acquires 524 Of Core Laboratories Inc [CLB] - TradingView
Will Core Laboratories Inc. stock continue dividend increasesTrade Volume Summary & Weekly Stock Breakout Alerts - Newser
Tetra Technologies (NYSE:TTI) versus Core Laboratories (NYSE:CLB) Head to Head Review - Defense World
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL - Quantisnow
Aug Selloffs: Can Core Laboratories Inc. stock surprise with earnings upsideWeekly Trade Report & AI Forecasted Stock Moves - moha.gov.vn
Core Laboratories (NYSE:CLB) Stock Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
What is Core Laboratories Inc (CLB) Price Targets? - fostersleader.com
P/E Ratio Insights for Core Laboratories - Benzinga
Core Laboratories (NYSE:CLB) Stock Passes Above 200-Day Moving Average – What’s Next? - Defense World
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):